Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly gross margin; no daily interpolation. Q1 FY2027 (2026-07-31): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
0.00%
GROSS MARGIN AVG 20Y
0.00%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
PharmaCyte Biotech, Inc.
Market Cap
$4.53M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.55M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.40M
Gross Margin
26.32%
TTM Avg
-195.38%
3Y Avg
-178.16%
5Y Avg
-96.97%
Market Cap
$4.72M
Gross Margin
19.34%
TTM Avg
59.23%
3Y Avg
54.62%
5Y Avg
36.41%
Market Cap
$4.32M
Gross Margin
31.52%
TTM Avg
25.06%
3Y Avg
26.02%
5Y Avg
31.75%
Market Cap
$4.86M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$4.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | $4.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | 0.00% | 0.00% | 0.00% | 0.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | 26.32% | -195.38% | -178.16% | -96.97% |
| CalciMedica, Inc. (CALC)vs › | $4.69M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $4.71M | 0.00% | 0.00% | 25.00% | 50.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | 19.34% | 59.23% | 54.62% | 36.41% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | 31.52% | 25.06% | 26.02% | 31.75% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | 100.00% | 100.00% | 100.00% | 100.00% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 0.00% |
| 2018-04-30 | 0.00% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 0.00% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | 0.00% |
| 2016-07-31 | 0.00% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
| 2015-10-31 | 0.00% |
| 2015-07-31 | 0.00% |
| 2015-04-30 | 0.00% |
| 2015-01-31 | 0.00% |
| 2014-10-31 | 0.00% |
| 2014-07-31 | 0.00% |
| 2014-04-30 | 0.00% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 0.00% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2012-10-31 | -53.01% |
| 2012-07-31 | 100.00% |
| 2012-04-30 | 167.94% |
| 2012-01-31 | 89.09% |
| 2011-10-31 | 69.58% |
| 2011-07-31 | 20.68% |
| 2011-04-30 | 99.33% |
| 2011-01-31 | 31.36% |
| 2010-10-31 | 82.02% |
| 2010-07-31 | 74.31% |
| 2010-04-30 | -80.20% |
| 2010-01-31 | 39.58% |
| 2009-10-31 | 25.94% |
| 2009-07-31 | 38.49% |
| 2009-04-30 | -256.91% |
| 2009-01-31 | 76.01% |
| 2008-10-31 | 58.29% |
| 2008-07-31 | 81.25% |
| 2008-04-30 | 77.99% |
| 2008-01-31 | 80.91% |
| 2007-10-31 | 80.86% |
| 2007-07-31 | 70.93% |
| 2007-04-30 | 0.00% |
| 2007-01-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 24.67% |
| 2005-04-30 | 42.88% |
| 2005-01-31 | 53.64% |
| 2004-10-31 | 87.68% |
| 2004-07-31 | 66.91% |
| 2004-04-30 | 0.00% |
| 2004-01-31 | 0.00% |
| 2003-10-31 | 0.00% |
| 2003-07-31 | 0.00% |
| 2003-04-30 | 0.00% |
| 2003-01-31 | 0.00% |
